Literature DB >> 16247065

An open study of botulinum-A toxin treatment of trigeminal neuralgia.

E J Piovesan1, H G Teive, P A Kowacs, M V Della Coletta, L C Werneck, S D Silberstein.   

Abstract

Thirteen subjects with trigeminal neuralgia were treated with botulinum-A neurotoxin (BoNT/A) in an open-label pilot study. After BoNT/A, visual analog scale score, surface area of pain, and therapeutic coefficient were reduced in all patients and for all branch trigeminal nerves studied. Therefore, BoNT/A is an efficient treatment. There were no major side effects. A placebo-controlled clinical trial is needed to confirm these findings.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16247065     DOI： 10.1212/01.wnl.0000180940.98815.74

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  37 in total

Review 1.  Use of botulinum toxin in the neurology clinic.

Authors:  Erle C H Lim; Raymond C S Seet
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

2.  A new target for the treatment of trigeminal neuralgia with botulinum toxin type A.

Authors:  Chuanjie Wu; Nanchang Xie; Hongbo Liu; Haifeng Zhang; Lu Zhang; Yajun Lian
Journal:  Neurol Sci       Date:  2017-10-30       Impact factor: 3.307

Review 3.  Refractory trigeminal neuralgia. Non-surgical treatment options.

Authors:  Giorgio Cruccu; Andrea Truini
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

4.  Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior.

Authors:  Marc J Marino; Tetsuji Terashima; Joanne J Steinauer; Kelly A Eddinger; Tony L Yaksh; Qinghao Xu
Journal:  Pain       Date:  2013-12-11       Impact factor: 6.961

5.  Treatment options in trigeminal neuralgia.

Authors:  Mark Obermann
Journal:  Ther Adv Neurol Disord       Date:  2010-03       Impact factor: 6.570

Review 6.  Comparative evaluation of surgical procedures for trigeminal neuralgia.

Authors:  Monika Parmar; Neha Sharma; Vikas Modgill; Purushotham Naidu
Journal:  J Maxillofac Oral Surg       Date:  2012-11-29

Review 7.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 8.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 9.  Cranial neuralgias: from physiopathology to pharmacological treatment.

Authors:  Roberto De Simone; Angelo Ranieri; Leonilda Bilo; Chiara Fiorillo; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2008-05       Impact factor: 3.307

10.  Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.

Authors:  Roshni Ramachandran; Carmen Lam; Tony L Yaksh
Journal:  Neurobiol Dis       Date:  2015-05-06       Impact factor: 5.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.